|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/07/20 National Research Corp. 10-Q 6/30/20 66:6.1M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 607K
2: EX-10.1 Material Contract HTML 306K
3: EX-10.2 Material Contract HTML 23K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
6: EX-32 Certification -- §906 - SOA'02 HTML 21K
13: R1 Document And Entity Information HTML 73K
14: R2 Condensed Consolidated Balance Sheets (Current HTML 118K
Period Unaudited)
15: R3 Condensed Consolidated Balance Sheets (Current HTML 39K
Period Unaudited) (Parentheticals)
16: R4 Condensed Consolidated Statements of Income HTML 87K
(Unaudited)
17: R5 Condensed Consolidated Statements of Comprehensive HTML 38K
Income (Unaudited)
18: R6 Condensed Consolidated Statements of Shareholders' HTML 61K
Equity (Unaudited)
19: R7 Condensed Consolidated Statements of Shareholders' HTML 33K
Equity (Unaudited) (Parentheticals)
20: R8 Condensed Consolidated Statements of Cash Flows HTML 110K
(Unaudited)
21: R9 Note 1 - Summary of Significant Accounting HTML 105K
Policies
22: R10 Note 2 - Contracts With Customers HTML 65K
23: R11 Note 3 - Income Taxes HTML 26K
24: R12 Note 4 - Notes Payable HTML 35K
25: R13 Note 5 - Share-based Compensation HTML 62K
26: R14 Note 6 - Goodwill and Other Intangible Assets HTML 39K
27: R15 Note 7 - Property and Equipment HTML 29K
28: R16 Note 8 - Earnings Per Share HTML 59K
29: R17 Note 9 - Related Party HTML 27K
30: R18 Note 10 - Segment Information HTML 39K
31: R19 Significant Accounting Policies (Policies) HTML 116K
32: R20 Note 1 - Summary of Significant Accounting HTML 69K
Policies (Tables)
33: R21 Note 2 - Contracts With Customers (Tables) HTML 60K
34: R22 Note 4 - Notes Payable (Tables) HTML 29K
35: R23 Note 5 - Share-based Compensation (Tables) HTML 57K
36: R24 Note 6 - Goodwill and Other Intangible Assets HTML 40K
(Tables)
37: R25 Note 7 - Property and Equipment (Tables) HTML 28K
38: R26 Note 8 - Earnings Per Share (Tables) HTML 56K
39: R27 Note 10 - Segment Information (Tables) HTML 34K
40: R28 Note 1 - Summary of Significant Accounting HTML 70K
Policies (Details Textual)
41: R29 Note 1 - Summary of Significant Accounting HTML 25K
Policies - Amortization Expense Classification
(Details)
42: R30 Note 1 - Summary of Significant Accounting HTML 28K
Policies - Allowance for Doubtful Accounts
(Details)
43: R31 Note 1 - Summary of Significant Accounting HTML 32K
Policies - Fair Value of Financial Assets and
Liabilities (Details)
44: R32 Note 2 - Contracts With Customers 1 (Details HTML 26K
Textual)
45: R33 Note 2 - Contracts With Customers 2 (Details HTML 28K
Textual)
46: R34 Note 2 - Contracts With Customers - Disaggregation HTML 34K
of Revenue (Details)
47: R35 Note 2 - Contracts With Customers - Information HTML 40K
About Receivables, Contract Assets, and Contract
Liabilities From Contracts With Customers
(Details)
48: R36 Note 3 - Income Taxes (Details Textual) HTML 23K
49: R37 Note 4 - Notes Payable (Details Textual) HTML 60K
50: R38 Note 4 - Notes Payable - Summary of Notes Payable HTML 30K
(Details)
51: R39 Note 5 - Share-based Compensation (Details HTML 87K
Textual)
52: R40 Note 5 - Share-based Compensation - Stock Options HTML 30K
Valuation Assumptions (Details)
53: R41 Note 5 - Share-based Compensation - Stock Option HTML 63K
Activity Under Equity Incentive Plans and Director
Plan (Details)
54: R42 Note 5 - Share-based Compensation - Non-vested HTML 35K
Stock (Details)
55: R43 Note 6 - Goodwill and Other Intangible Assets - HTML 23K
Summary of Changes in the Carrying Amount of
Goodwill (Details)
56: R44 Note 6 - Goodwill and Other Intangible Assets - HTML 35K
Summary of Goodwill and Intangible Assets
(Details)
57: R45 Note 7 - Property and Equipment - Summary of HTML 27K
Property and Equipment (Details)
58: R46 Note 8 - Earnings Per Share (Details Textual) HTML 23K
59: R47 Note 8 - Earnings Per Share - Net Income Per Share HTML 56K
Computation (Details)
60: R48 Note 9 - Related Party (Details Textual) HTML 30K
61: R49 Note 10 - Segment Information (Details Textual) HTML 23K
62: R50 Note 10 - Segment Information - Assets by HTML 29K
Geographic Area (Details)
64: XML IDEA XML File -- Filing Summary XML 119K
12: XML XBRL Instance -- nrc20200630_10q_htm XML 1.26M
63: EXCEL IDEA Workbook of Financial Reports XLSX 64K
8: EX-101.CAL XBRL Calculations -- nrc-20200630_cal XML 120K
9: EX-101.DEF XBRL Definitions -- nrc-20200630_def XML 980K
10: EX-101.LAB XBRL Labels -- nrc-20200630_lab XML 826K
11: EX-101.PRE XBRL Presentations -- nrc-20200630_pre XML 1.00M
7: EX-101.SCH XBRL Schema -- nrc-20200630 XSD 142K
65: JSON XBRL Instance as JSON Data -- MetaLinks 304± 470K
66: ZIP XBRL Zipped Folder -- 0001437749-20-016985-xbrl Zip 255K
Exhibit 10.2
FORM OF GRANT USED IN CONNECTION WITH THE NATIONAL RESEARCH CORPORATION
2004 NON-EMPLOYEE DIRECTOR STOCK PLAN, AS AMENDED
[Director name]
Re: Stock Option Grant National Research Corporation Director Stock Plan
This letter is to confirm that on [date], you were automatically granted a nonqualified stock option to purchase [# of shares] shares of Common Stock, $.001 par value, of National Research Corporation (“Company”) pursuant to the terms of the 2004 Non-Employee Director Stock Plan (the “Plan”).
Your stock option to purchase up to [# of shares] shares of Common Stock is subject to the terms and conditions of the Plan. The option price is [price] per share, which was the last sale price of a share of Common Stock on the NASDAQ Stock Market on [date of grant], the date of grant.
In accordance with the terms of the Plan, when your options are granted on an “Annual Grant Date” (i.e., the date of the Company’s Annual Meeting of Shareholders) such options are not exercisable until the day immediately preceding the next following Annual Grant Date (the “Vesting Date”), unless your status as a director of the Company terminates because of death prior to that time, in which event the options become immediately exercisable in full and may be exercised for a period of three (3) years after the date of death. If for any reason other than death you cease to be an outside director of the Company prior to the Vesting Date, the options will be cancelled as of the date of such termination. Subject to the foregoing, the options expire ten (10) years after the date of grant, or if earlier, three (3) years after you cease to be an outside director of the Company.
The other terms which govern your stock options are as set forth below and as provided in the Plan.
Procedure for Exercise. You may exercise your options in whole or in part at any time after the options have become exercisable (as discussed above) by delivering written notice to the Company together with payment of the option price in cash, previously acquired shares of Common Stock valued at their fair market value or such other forms as the Board or Plan administrator approves.
Securities Laws Matters. Applicable federal and state securities laws govern the disposition by you of shares purchased through the exercise of your options. You may sell such shares only (1) pursuant to an effective registration statement under the Securities Act of 1933, as amended (“Act”), or (2) in a transaction which is exempt from registration under the Act, such as a sale which fully complies with Rule 144 under the Act.
Non-Transferability. Your options may not be sold or transferred other than by will or under the laws of descent and distribution, except that an option may be transferred to the extent allowed by the Board or the Plan administrator. The designation of a beneficiary will not constitute a transfer.
Conformity with Plan. Your options are intended to conform in all respects with, and are subject to all applicable provisions of, the Plan. Inconsistencies between this letter and the Plan will be resolved in accordance with the terms of the Plan.
Please execute and return the enclosed copy of this letter to the Company. By doing so, you agree to be bound by all of the terms of this letter and of the Plan.
Very truly yours,
NATIONAL RESEARCH CORPORATION
| By: [Authorized Officer] |
Accepted on this _____ day of _______________, [yyyy].
| [Director name], Director |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/27/24 National Research Corp. 10-K 12/31/23 91:9.5M RDG Filings/FA 3/03/23 National Research Corp. 10-K 12/31/22 90:9M RDG Filings/FA 3/04/22 National Research Corp. 10-K 12/31/21 91:8.5M RDG Filings/FA 3/05/21 National Research Corp. 10-K 12/31/20 89:9M RDG Filings/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/23/20 National Research Corp. 8-K:5,9 3/19/20 2:149K RDG Filings/FA 4/20/18 National Research Corp. 8-K:1,2,3,5 4/16/18 4:1M RDG Filings/FA |